Most provinces have no plans to reimpose COVID-19 restrictions as cases surge - National | Globalnews.ca

  • 📰 GlobalNational
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Most provinces have no plans to reimpose COVID-19 restrictions as cases surge

to get provinces to bring back serious restrictions — but none are willing to divulge exact figures of just how much worse things would have to get.

“We do not expect to see the hospitals strained as they were in the initial omicron wave but we’ll continue to monitor closely,” said Steve Buick, a spokesperson for Alberta’s health minister, in an emailed statement. Buick said there’s “no single numerical threshold” for returning to COVID rules, but rather it’s a “judgment that would weigh all the indicators of risk of overburdening the health system.”COVID-19 will be with us for ‘foreseeable future’ PHAC says, warning of future waves

Fitzgerald reiterated, though, that the province’s health-care system should be able to manage the current projections — as did a spokesperson from PEI’s government.COVID-19: Quebec extends mask mandate to late April As things stand now, only Nunavut, P.E.I. and Quebec still have their mask mandates in place. Nunavut is slated to drop the requirement on Monday, however, while Quebec just extended the rule amid rising COVID cases.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 81. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA pulls authorization for GSK-Vir’s COVID-19 therapy amid rising Omicron sub-variant casesThe U.S. health regulator pulls its authorization for GSK-Vir’s COVID-19 therapy in the U.S. The move comes as a blow as GlaxoSmithKline and Vir saw high demand for sotrovimab
Source: globeandmail - 🏆 5. / 92 Read more »